MedEsthetics
OCTOBER 21, 2024
65% of readers said they are currently offering regenerative treatments (PRP, exosome therapies, etc.) at their medspa or practice! Here are four advantages of offering your patients regenerative treatments.
Dermatology Times
OCTOBER 21, 2024
Christophe Bourdon, CEO, discusses LEO Pharma's groundbreaking presentations at EADV, delgocitinib's US pending approval, and the company's commitment to addressing chronic hand eczema.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedEsthetics
OCTOBER 21, 2024
According to a market analysis report conducted in 2023 from Grand View Research, the global retinol market for beauty products is expected to reach $1.79 billion by 2030, growing at an annual rate of 3.8%.
Dermatology Times
OCTOBER 21, 2024
Lio addresses one of the NEA's Eczema Awareness Month weekly themes, "What is eczema?
MedEsthetics
OCTOBER 21, 2024
Lead scientist of luxury brand reveals recent findings that may shape the future of inflammation skin care products.
Salon Today
OCTOBER 21, 2024
The lucky salon, based in Inver Grove, MN, captured more than 50% of the incoming 4,400 votes in the color bar makeover competition.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
The Skin Institute
OCTOBER 21, 2024
Creating a soothing and relaxing esthetician studio can enhance the service experience. Estheticians already do their best to provide a relaxing experience, but making a calming studio can help new and returning clients feel serene. In this blog, we will share some tips on how you can create a studio that fits your personality but provides stress relief for all clients.
Beauty Launchpad
OCTOBER 21, 2024
Nine talented stylists from throughout the U.S. have been named official members of the newly formed Danger Jones Balayage Team.
Dermatology Times
OCTOBER 21, 2024
Whether you're a novice or a seasoned expert, there's always more to learn and refine, ensuring that dermatology continues to advance with precision and care.
The Dermatology Digest
OCTOBER 21, 2024
More than half of dermatomyositis patients are not optimally managed, according to a survey of 102 U.S. rheumatologists and dermatologists by Spherix Global Insights. Currently, the standard of care predominantly involves corticosteroids, topical therapies, traditional disease-modifying anti-rheumatic drugs (tDMARDs), and, in more severe or refractory cases, intravenous immunoglobulin (IVIg) or off-label biologics, underscoring the growing unmet need for novel therapeutic options to treat this c
Dermatology Times
OCTOBER 21, 2024
A recent study revealed that patients with HS have a 23% prevalence of IA, emphasizing the need for routine screening in dermatologic practice.
US Dermatologt Partners
OCTOBER 21, 2024
Many young adults who dealt with acne as teens experience breakouts during college when changes in lifestyle increase risk acne risk. According to Dr. Hans Sander of U.S. Dermatology Partners Jollyville, “Acne is common in the teen years and early 20s, so it’s no surprise that college students often deal with this condition. When young adults are at home, parents may be keeping track of their skincare routine and making sure they get to the dermatologist regularly, but young adults are less like
Dermatology Times
OCTOBER 21, 2024
Song stressed the need for careful therapy selection in patients with comorbid conditions to avoid exacerbating health issues.
The Dermatology Digest
OCTOBER 21, 2024
People living with atopic dermatitis may be at significantly higher risk for peripheral vascular disease (PVD), Yale School of Medicine researchers report in Clinical and Experimental Dermatology. Using data from the All of Us Research Program, a National Institutes of Health database of more than 260,000 diverse American adults, the Yale team found PVD occurred in 11% of patients with AD, but just 6.2% of patients without AD.
Dermatology Times
OCTOBER 21, 2024
Anthony M. Rossi, MD, discusses common barriers to implementing photodynamic therapy (PDT), and provides solutions to specific challenges in the treatment setting.
The Dermatology Digest
OCTOBER 21, 2024
Castle’s DecisionDx-Melanoma and DecisionDx-SCC tests can guide risk-aligned treatment decisions, including sentinel lymph node biopsy (SLNB) for patients with melanoma and surveillance imaging for those with cutaneous squamous cell carcinoma (cSCC), according to data presented in two video abstracts at the 2024 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Orlando, FL.
Dermatology Times
OCTOBER 21, 2024
Anthony M. Rossi, MD, highlights a successful case of photodynamic therapy (PDT), provides background on the patient’s outcome, and explains how increased use of PDT can enhance patient satisfaction and improve practice outcomes.
Dermatology Times
OCTOBER 21, 2024
Anthony M. Rossi, MD, shares their perspective on the future evolution of photodynamic therapy (PDT) in dermatology practices and discusses emerging data or studies that will be crucial for dermatologists to stay informed about.
Expert insights. Personalized for you.
113 
Let's personalize your content